MXPA03010467A - Production and use of a polar lipid-rich fraction containing stearidonic acid and gamma linolenic acid from plant seeds and microbes. - Google Patents

Production and use of a polar lipid-rich fraction containing stearidonic acid and gamma linolenic acid from plant seeds and microbes.

Info

Publication number
MXPA03010467A
MXPA03010467A MXPA03010467A MXPA03010467A MXPA03010467A MX PA03010467 A MXPA03010467 A MX PA03010467A MX PA03010467 A MXPA03010467 A MX PA03010467A MX PA03010467 A MXPA03010467 A MX PA03010467A MX PA03010467 A MXPA03010467 A MX PA03010467A
Authority
MX
Mexico
Prior art keywords
production
acid
microbes
polar lipid
gamma linolenic
Prior art date
Application number
MXPA03010467A
Other languages
Spanish (es)
Inventor
Ruben Abril Jesus
Original Assignee
Martek Biosciences Boulder Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Martek Biosciences Boulder Corp filed Critical Martek Biosciences Boulder Corp
Publication of MXPA03010467A publication Critical patent/MXPA03010467A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/158—Fatty acids; Fats; Products containing oils or fats
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A23L33/11—Plant sterols or derivatives thereof, e.g. phytosterols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/231—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having one or two double bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/232—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having three or more double bonds, e.g. etretinate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/927—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of insects, e.g. shellac
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Birds (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Polymers & Plastics (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Botany (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Mycology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Animal Husbandry (AREA)
  • Insects & Arthropods (AREA)
  • Transplantation (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Obesity (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Cosmetics (AREA)

Abstract

The production and use, and in particular, the extraction, separation, synthesis and recovery of polar lipid-rich fractions containing gamma linolenic acid (GLA) and/or stearidonic acid (SDA) from seeds and microorganisms and their use in human food applications, animal feed, pharmaceuticals and cosmetics.
MXPA03010467A 2001-05-14 2002-05-14 Production and use of a polar lipid-rich fraction containing stearidonic acid and gamma linolenic acid from plant seeds and microbes. MXPA03010467A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29148401P 2001-05-14 2001-05-14
PCT/US2002/015479 WO2002092073A1 (en) 2001-05-14 2002-05-14 Production and use of a polar lipid-rich fraction containing stearidonic acid and gamma linolenic acid from plant seeds and microbes

Publications (1)

Publication Number Publication Date
MXPA03010467A true MXPA03010467A (en) 2004-12-06

Family

ID=23120484

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03010467A MXPA03010467A (en) 2001-05-14 2002-05-14 Production and use of a polar lipid-rich fraction containing stearidonic acid and gamma linolenic acid from plant seeds and microbes.

Country Status (7)

Country Link
US (1) US20070004678A1 (en)
EP (2) EP2275101A1 (en)
JP (2) JP4728561B2 (en)
AU (3) AU2002318135B2 (en)
CA (2) CA2689808A1 (en)
MX (1) MXPA03010467A (en)
WO (1) WO2002092073A1 (en)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2255668A3 (en) * 2001-05-14 2012-04-04 Martek Biosciences Corporation Production and Use of a Polar Lipid-Rich Fraction Containing Omega-3 and/or Omega-6 Highly Unsaturated Fatty Acids from Microbes, Genetically Modified Plant Seeds and Marine Organisms
JP4499371B2 (en) * 2003-01-14 2010-07-07 株式会社 エフェクト Method for producing proanthocyanidins derived from peanuts
JP4541662B2 (en) * 2003-05-29 2010-09-08 オリザ油化株式会社 Anti-pylori composition
AR045290A1 (en) 2003-08-21 2005-10-19 Monsanto Technology Llc PRIMULA FAT DESATURASAS ACID
JP4313632B2 (en) * 2003-09-05 2009-08-12 ポーラ化成工業株式会社 Food composition
MY140210A (en) * 2003-12-22 2009-11-30 Suntory Holdings Ltd Marchantiales-derived unsaturated fatty acid synthetase genes and use of the same
JP2007533310A (en) 2004-04-16 2007-11-22 モンサント テクノロジー エルエルシー Expression of fatty acid desaturase in maize
US20050266051A1 (en) * 2004-05-27 2005-12-01 The Procter & Gamble Company Pet food compositions and methods
AR051421A1 (en) 2004-11-04 2007-01-10 Monsanto Technology Llc COMPOSITIONS OF RICH OILS IN POLYINSATURATED FATTY ACIDS (PUFA)
ES2703217T3 (en) * 2005-11-18 2019-03-07 Commw Scient Ind Res Org Feed for aquaculture comprising foods containing stearidonic acid for aquaculture
BR122018075948B1 (en) 2006-03-10 2023-05-16 Monsanto Technology Llc METHODS OF PRODUCING A SOYBEAN PLANT WITH CHANGED SEED FATTY ACID CONTENT
US20080043087A1 (en) * 2006-07-19 2008-02-21 James Cowan Digital transfer method for printing on a target surface
EP2117335A4 (en) * 2007-01-03 2013-05-01 Monsanto Technology Llc Food compositions incorporating stearidonic acid.
US10045951B2 (en) * 2007-05-25 2018-08-14 The Trustees Of The University Of Pennsylvania Flaxseed lignan complex and its use thereof
WO2008147563A1 (en) 2007-05-25 2008-12-04 The Trustees Of The University Of Pennsylvania Flaxseed lignan complex, methods of using and compositions thereof
NZ583662A (en) * 2007-08-17 2012-04-27 Murray Goulburn Coop Co Ltd Compositions comprising phospholipids
US20090064567A1 (en) 2007-09-12 2009-03-12 Martek Biosciences Corporation Biological oils and production and uses Thereof
US8343753B2 (en) * 2007-11-01 2013-01-01 Wake Forest University School Of Medicine Compositions, methods, and kits for polyunsaturated fatty acids from microalgae
CA2704371A1 (en) * 2007-11-01 2009-05-07 Wake Forest University School Of Medicine Compositions and methods for prevention and treatment of mammalian diseases
EP3153030B1 (en) 2007-11-29 2019-03-27 Monsanto Technology LLC Meat products with increased levels of beneficial fatty acids
AR070320A1 (en) * 2008-01-29 2010-03-31 Monsanto Technology Llc METHODS FOR FEEDING PIGS AND PRODUCTS THAT INCLUDE BENEFIT FAT ACIDS
US20090197955A1 (en) * 2008-01-31 2009-08-06 Monsanto Company Methods of improving dha deposition and related function and/or development
US20090202672A1 (en) * 2008-02-11 2009-08-13 Monsanto Company Aquaculture feed, products, and methods comprising beneficial fatty acids
US20110237851A1 (en) * 2008-04-25 2011-09-29 Conocophillips Company Thermal cracking of impurities in triglyceride feedstock
GB0814105D0 (en) 2008-08-01 2008-09-10 Springdale Sustainable Develop Composition for accelerated production of collagen
EP2338060A1 (en) * 2008-09-25 2011-06-29 Biosystems International SAS Methods of detecting and treating pulmonary disease and markers thereof
JP2010079993A (en) * 2008-09-26 2010-04-08 Toshiba Storage Device Corp Storage device and method for adjusting storage device
CA2751275A1 (en) 2009-02-02 2010-08-05 Martek Biosciences Corporation Use of docosahexaenoic acid in treating mild cognitive impairment
GB0902040D0 (en) 2009-02-06 2009-03-11 Seeds Lp Composition for treatment of skin
CA2755438C (en) * 2009-03-16 2016-10-11 Monsanto Technology Llc Poultry meat and eggs comprising beneficial fatty acids
US8323708B2 (en) * 2009-03-16 2012-12-04 Monsanto Technology Llc Poultry meat and eggs comprising beneficial fatty acids
EP2272383A1 (en) 2009-06-22 2011-01-12 SBAE Industries NV Composition Comprising Omega-7 and/or Omega-4 Fatty Acids
AU2010266593B2 (en) * 2009-06-30 2015-01-29 Monsanto Technology Llc Nut butter and related products enriched with omega-3
WO2011006144A1 (en) 2009-07-10 2011-01-13 Martek Biosciences Corporation Methods of treating and preventing neurological disorders using docosahexaenoic acid
US9480271B2 (en) 2009-09-15 2016-11-01 Monsanto Technology Llc Soybean seed and oil compositions and methods of making same
WO2011041710A2 (en) 2009-10-01 2011-04-07 Martek Biosciences Corporation Docosahexaenoic acid gel caps
SG185578A1 (en) 2010-06-14 2013-01-30 Io Mega Holding Corp Methods for the production of algae derived oils
US8563611B2 (en) * 2011-03-17 2013-10-22 Women's & Children's Health Research Institute Methods and compositions for promoting the respiratory development of an infant
WO2013024174A1 (en) 2011-08-18 2013-02-21 Dsm Ip Assets B.V. Dha triglyceride, dha free fatty acid, and dha ethyl ester emulsions, and methods of treating spinal cord injury
US20130316061A1 (en) 2011-11-01 2013-11-28 Michael Lenn Stefanski Oxidatively stable polyunsaturated fatty acid containing oil
KR101589825B1 (en) * 2014-03-25 2016-02-01 고려대학교 산학협력단 Method of enrichment highly purified stearidonic acid form from echium oil
CN106302571B (en) * 2015-05-14 2020-07-28 微软技术许可有限责任公司 System and method for maintaining and caching server connections
JP6885582B2 (en) * 2017-02-23 2021-06-16 御木本製薬株式会社 Transglutaminase activity promoter
CN115569093B (en) * 2022-09-09 2023-10-13 安徽亿人安股份有限公司 Infant dampness-dispelling skin-care cream with antibacterial effect and preparation method thereof

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2490631A1 (en) * 1980-09-24 1982-03-26 Roussel Uclaf NOVEL LIPID COMPOSITION FOR USE IN DIETETICS, REANIMATION AND THERAPEUTICS
GB8408974D0 (en) * 1984-04-06 1984-05-16 Efamol Ltd Food production
CH663951A5 (en) * 1984-10-10 1988-01-29 Nestle Sa PROCESS FOR THE SELECTIVE ENRICHMENT OF POLYUNSATURATED FATTY ACIDS IN A MIXTURE CONTAINING ENRICHED FRACTION FATTY ACIDS AND COMPOSITIONS CONTAINING THE SAME.
EP0246324B1 (en) * 1985-01-22 1993-01-27 Japan as represented by Director-General, Agency of Industrial Science and Technology Method for obtaining lipids from fungus bodies
GB8507058D0 (en) * 1985-03-19 1985-04-24 Efamol Ltd Pharmaceutical & dietary compositions
GB8621816D0 (en) * 1986-09-10 1986-10-15 Efamol Ltd Therapeutic composition
US4816271A (en) * 1987-01-16 1989-03-28 Adelia Scaffidi Skin lotions and creams
GB8813766D0 (en) * 1988-06-10 1988-07-13 Efamol Holdings Essential fatty acid compositions
ES2059880T3 (en) * 1990-05-23 1994-11-16 Nestle Sa USE OF STEARIDONIC ACID FOR THE TREATMENT OF INFLAMMATORY DISEASES.
GB9012651D0 (en) * 1990-06-06 1990-07-25 Efamol Holdings Essential fatty acid treatment
PH31293A (en) * 1991-10-10 1998-07-06 Rhone Poulenc Agrochimie Production of y-linolenic acid by a delta6-desaturage.
DE4219360C2 (en) * 1992-06-12 1994-07-28 Milupa Ag Process for the production of lipids with a high proportion of long-chain, highly unsaturated fatty acids
GB9217781D0 (en) * 1992-08-21 1992-10-07 Efamol Holdings Fatty acid treatment
EP0585058A1 (en) * 1992-08-25 1994-03-02 Scotia Holdings Plc Pharmaceutical compositions containing fatty acids and heparin
GB9423625D0 (en) * 1994-11-23 1995-01-11 Scotia Holdings Plc Fortified fruit juice
US5583019A (en) * 1995-01-24 1996-12-10 Omegatech Inc. Method for production of arachidonic acid
US6582941B1 (en) * 1995-04-17 2003-06-24 Japan As Represented By Director-General Of Agency Of Industrial Science And Technology Microorganisms capable of producing highly unsaturated fatty acids and process for producing highly unsaturated fatty acids by using the microorganisms
SE504664C2 (en) * 1995-09-22 1997-03-24 Scotia Lipidteknik Ab Methods for preparing fractional oil, the oil, its use and emulsion composition containing the oil
US5883273A (en) * 1996-01-26 1999-03-16 Abbott Laboratories Polyunsaturated fatty acids and fatty acid esters free of sterols and phosphorus compounds
US6080787A (en) * 1997-02-21 2000-06-27 Abbott Laboratories Methods for reducing the incidence of necrotizing enterocolitis
US5968809A (en) * 1997-04-11 1999-10-19 Abbot Laboratories Methods and compositions for synthesis of long chain poly-unsaturated fatty acids
US5993221A (en) * 1997-05-01 1999-11-30 Beth Israel Deaconess Medical Center, Inc. Dietary formulation comprising arachidonic acid and methods of use
GB9715203D0 (en) * 1997-07-19 1997-09-24 Piper Edwina M Composition
DE19757414A1 (en) * 1997-12-23 1999-07-01 Nutricia Nv Fat blend
US6107334A (en) * 1998-02-23 2000-08-22 Wake Forest University Dietary control of arachidonic acid metabolism
EP2255668A3 (en) * 2001-05-14 2012-04-04 Martek Biosciences Corporation Production and Use of a Polar Lipid-Rich Fraction Containing Omega-3 and/or Omega-6 Highly Unsaturated Fatty Acids from Microbes, Genetically Modified Plant Seeds and Marine Organisms
ATE363486T1 (en) * 2001-07-27 2007-06-15 Neptune Technologies & Bioress NATURAL PHOSPHOLIPIDS OF MARITIME ORIGIN CONTAINING FLAVONOIDS AND POLYUNSATURATED FATTY ACIDS AND THEIR APPLICATIONS

Also Published As

Publication number Publication date
EP1392278A1 (en) 2004-03-03
EP1392278A4 (en) 2005-05-04
US20070004678A1 (en) 2007-01-04
JP4728561B2 (en) 2011-07-20
AU2007225606A1 (en) 2007-11-01
WO2002092073A1 (en) 2002-11-21
AU2007225606B2 (en) 2009-06-04
EP2275101A1 (en) 2011-01-19
JP2004536801A (en) 2004-12-09
CA2446059A1 (en) 2002-11-21
CA2446059C (en) 2010-03-23
CA2689808A1 (en) 2002-11-21
JP2010229144A (en) 2010-10-14
AU2009212905A1 (en) 2009-10-01
AU2002318135B2 (en) 2007-08-02

Similar Documents

Publication Publication Date Title
MXPA03010467A (en) Production and use of a polar lipid-rich fraction containing stearidonic acid and gamma linolenic acid from plant seeds and microbes.
GB2396026B (en) Integration of graphic display elements, process modules and control modules in process plants
HUP0301939A2 (en) Novel probiotics for pet food applications
GB2406038B (en) Appliances for extracting juice and pulp from plant products with improved yields
EP3170410A3 (en) Processing of natural polysaccharides by selected non-pathogenic microorganisms and methods of making and using the same
WO2004071178A3 (en) Annexin and p34 promoters and use in expression of transgenic genes in plants
MY142017A (en) Composition comprising all essential nutrients of a fruit or a plant material with increased stability and bioavailability and process of forming the same
AU2003223990A1 (en) Filtration devices
WO2003101923A3 (en) Policosanol compositions, extraction from novel sources, and uses thereof
ATE433670T1 (en) FEED COMPOSITION
MX2007011900A (en) Reproductive cell system.
TWI350313B (en) Direct smelting plant and process
MXPA05002603A (en) Juice purification system.
IL162903A0 (en) Granulated product and process to prepare the same
MXPA05011209A (en) Particulate-based ingredient delivery system.
ATE527875T1 (en) INCREASING OIL CONTENT IN BRASSICA PLANTS
ZA200603111B (en) Direct smelting plant and process
MXPA02009612A (en) Sequence regulating the anther specific expression of a gene and its use in the production of androsterile plants and hybrid seeds.
SE0103693D0 (en) Zeolites as matrix
AU2003208343A1 (en) Identification labels in plants or plant parts
WO2004023889A3 (en) Full range nutritional supplements from plant materials and methods for their manufacture
AU2002349829A8 (en) Production process for plant biomass and its use
UA67514C2 (en) Biological fertilizer with immune properties
WO2001075131A3 (en) Expression of uncoupling protein (ucp) in plants
AU2003205079A1 (en) Fibrous product containing plant seed

Legal Events

Date Code Title Description
FG Grant or registration